Tom 3, Nr 3 (2010)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2010-10-05
Wyświetlenia strony
593
Wyświetlenia/pobrania artykułu
1225
Alloimmunologiczna małopłytkowość płodowo-noworodkowa
Journal of Transfusion Medicine 2010;3(3):106-108.
Streszczenie
Brak
Referencje
- Bierling P, Bux J, Curtis B, et al. ISBT Working Party on Granulocyte Immunobiology. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang. 2009; 96(3): 266–269.
- Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis. 1983; 128(1): 185–189.
- Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002; 287(15): 1968–1971.
- Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007; 109(4): 1752–1755.
- Reil A, Keller-Stanislawski B, Günay S, et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008; 95(4): 313–317.
- Sachs UJH, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006; 107(3): 1217–1219.
- Sachs UJH, Wasel W, Bayat B, et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood. 2011; 117(2): 669–677.
- Zupańska B, Uhrynowska M, Konopka L. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria. Transfusion. 1999; 39(9): 944–947.
- Uhrynowska M, Szczepanik AB, Konopka L, et al. Transfusion-related acute lung injury — diagnostic problems. Acta Haemat Pol. 2003; 34: 507–512.
- Zupańska B, Uhrynowska M, Maślanka K, et al. [Transfusion-Related Acute Lung Injury a serious, underdiagnosed transfusion-related event]. Pol Merkur Lekarski. 2006; 20(119): 514–518.
- Zupanska B, Uhrynowska M, Michur H, et al. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sanguinis. 2007; 93(1): 70–77.
- Uhrynowska M, Maślanka K, Guz K, et al. case of transfusion related acute respiratory failure caused by human neutrophil antibodies — diagnostic difficulties. Acta Haemat Pol. 2011; 42: 593–596.
- Maślanka K, Uhrynowska M, Łopacz P, et al. Incidence of leukocyte reacting antibodies in patients with dyspnea-associated non-hemolytic transfusion reactions and in the transfused blood components. J. Transf. Med. 2012; P27: ahead of print.
- Maślanka K, Michur H, Zupańska B, et al. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang. 2007; 92(3): 247–249.
- Silliman CC, Voelkel NF, Allard D, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998; 101: 1458–1467.
- Silliman CC, Fung YL, Ball JB, et al. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009; 23(6): 245–255.
- Silliman CC, Moore EE, Kelher MR, et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion. 2011; 51: 2549–2554.
- Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996; 36(2): 133–139.
- Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997; 37(7): 719–726.
- Maślanka K, Smoleńska-Sym G, Michur H, et al. Bioactive lipids: is lysophosphtidylcholine generated during storage of blood components? Vox Sang. 2010; 99(suppl. 1): 452.
- Maślanka K, Smoleńska-Sym G, Michur H, et al. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz). 2012; 60(1): 55–60.
- Sachs UJ, Weissmann N, Wasel W, et al. Supernatants from stored leukodepleted packed red blood cells do not regular exhibit changes in their (lyso–)phosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang. 2010; 99(suppl.1): 456.
- Vlaar APJ, Kulik W, Nieuwland R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011; 51(11): 2358–2366.
- Łopacz P, Wróbel A, Sak-Budzisz J, et al. Evaluation of the concentration of IL-1beta, IL-6, IL-8, TNFalfa and sCD40L cytokines in stored erythrocyte and platelet concentrates. Acta Haemat Pol. 2011; 42: 85–93.
- Maślanka K, Michur H, Wróbel A, et al. Microparticles in stored red blood cells and platelet concentrates. Vox Sang. 2010; 99(suppl. 2): 30.
- Rosiek A, Dzieciątkowska A, Lachert E, et al. Blood transfusion service in Poland 2009. J Transf Med. 2010; 4: 133–143.
- Lachert E. Roztwory wzbogacające do przechowywania koncentratów krwinek płytkowych. Laboratorium. 2008; 4: 32–36.
- Lachert E, Łętowska M. Methods of pathogen inactivation in blood products. Acta Haemat Pol. 2011; 42: 425–434.
